Deerfield Management Company, L.P. (Series C) has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $3.95 Billion distributed in 123 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $1.28B, Viatris Inc with a value of $209M, Neurocrine Biosciences Inc with a value of $165M, Centene Corp with a value of $162M, and Oscar Health, Inc. with a value of $155M.

Examining the 13F form we can see an decrease of $88.1M in the current position value, from $4.04B to 3.95B.

Deerfield Management Company, L.P. (Series C) is based out at New York, NY

Below you can find more details about Deerfield Management Company, L.P. (Series C) portfolio as well as his latest detailed transactions.

Portfolio value $3.95 Billion
Healthcare: $3.95 Billion
Real Estate: $591,000
Technology: $483,000
Consumer Cyclical: $347,000
Energy: $314,000
Communication Services: $99,000
Industrials: $47,000

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 123
  • Current Value $3.95 Billion
  • Prior Value $4.04 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 47 stocks
  • Additional Purchases 20 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.